Updated:
Olive Tree Capital
Olive Tree Capital is a venture capital firm founded in 2013 in Boston, Massachusetts. It invests in technology and life sciences companies, focusing on...
Olive Tree Capital
Olive Tree Capital is a venture capital firm founded in 2013 in Boston, Massachusetts. It invests in technology and life sciences companies, focusing on sectors such as healthcare, financial technologies, and AI. The firm has made 106 investments, including a Series B - III investment in Phoenix Tailings on February 18, 2026.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Principals
Nichola Eliovits
Team
Mickael Chane-Du
Team
Ashan Walpita
Team
Joseph Lissak
Team
Isaac Btesh
Team
Sector focus
Frequently asked questions
Does Olive Tree Capital participate in fund commitments or only direct deals?
Olive Tree's stated strategy includes fund-of-funds activity alongside direct venture, growth equity, secondaries, and PIPEs. The firm therefore commits to external managers as well as making direct company investments, though the public portfolio page emphasizes company-level positions.
Which sectors does Olive Tree Capital explicitly avoid?
The firm does not publish an exclusion list or negative screening criteria. Its public portfolio reveals no positions in defense primes, extractive industries, or consumer packaged goods. The concentration is overwhelmingly in technology, financial services, healthcare, and frontier engineering.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: